CONSULTING AGREEMENT
This
Consulting Agreement (“Agreement”) is entered into as of January 26, 2007
(“Effective Date”), by and between PACE Health Management Systems, Inc., an Iowa
corporation (the “Company”), and Yankee Partners, LLC (the
“Consultant”).
In
consideration of the mutual covenants and conditions set forth herein, and
other
good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereby agree as follows:
1. Relationship
of the Parties.
(a)
Consultant agrees to perform services (the “Services”) for the Company relating
to the Mid-Atlantic Region programs of the Company, as well as management and
other services as agreed to by Consultant and the Company.
(b) In
the
performance of the Services, Consultant shall act solely as an independent
contractor, and nothing herein shall at any time be construed to create the
relationship of employer and employee, partnership, principal and agent, or
joint venture as between the Company and Consultant. Neither party shall have
any right or authority to, nor will either party attempt to enter into any
contract, commitment or agreement, or to incur any debt or liability of any
nature, in the name, or on behalf, of the other party.
2. Term.
The
term of this Agreement shall commence as of January 26, 2007 (the “Commencement
Date”), and end on the one year anniversary of the Commencement Date (the
“Initial Term”), unless earlier terminated as provided in Section 4 or 5 hereof.
This Agreement shall be automatically renewed for successive one-year periods
thereafter, commencing upon the expiration of the Initial Term, unless earlier
terminated as provided in Section 4 or 5 hereof. Consultant shall, following
the
Commencement Date, provide its Services to the Company on a full-time business
basis requiring the devotion of 5 days per week of its productive business
time
for the efficient and successful operation of the business of the
Company.
3. Compensation
and Benefits.
3.1 Cash
Compensation.
For the
performance of Consultant’s Services hereunder following the Commencement Date,
the Company shall pay Consultant a per diem amount equal to $730.77 per day
(the
“Per Diem Amount”) for each day worked on behalf of the Company, or such greater
amount as may be agreed upon by the parties. On the first of each month,
Consultant shall submit to the Company for approval a tentative monthly schedule
indicating Consultant’s anticipated performance time, including, without
limitation, days, hours and locations relating to Consultant’s performance of
its Services on behalf of the Company, as well as Consultant’s travel dates and
travel time. In the event Consultant is traveling and works a two shift day
providing Services as a physician’s assistant at any of the detention facilities
set forth on Schedule I attached hereto, as indicated by overnight stays on
both
the day immediately prior and after the working day, then Consultant’s Per Diem
Amount will be equal to two (2) days work or $1,461.54. Consultant shall submit
biweekly time sheets in accordance with Company policy which shall be due by
10:00 AM on the first Monday following the end of the Company’s biweekly pay
period.
1
3.2 Additional
Compensation; Incentive Compensation.
(a) Company
may, in its sole discretion, pay additional compensation (“Additional
Compensation”) to Consultant based upon the performance of its Services. The
amount of the Additional Compensation, which is not to exceed an aggregate
of
$40,000 annually, shall be based on Consultant’s ability to maintain the
Company’s current business and revenues generated by all Maryland sites for the
year 2007 (the “Maryland Accounts”), such amount to be prorated against each
Maryland Account. A list of the Maryland Accounts and the prorated Additional
Compensation amounts are set forth on Schedule I attached hereto.
Notwithstanding the foregoing, in the event the revenues generated by any
individual Maryland Account are equal to an amount less than the stipulated
revenue amount for such year, such revenues shall not be included in calculating
the Additional Compensation amount.
(b) Further,
in the event Consultant generates New Business Services (as defined below)
on
behalf of the Company, the Company shall pay to Consultant an incentive
compensation (“Incentive Compensation”) amount equal to one half (1/2) of one
percent (1%) of the first twelve (12) months of gross revenue actually collected
and received by the Company from each New Business Service, provided,
however,
that
the gross revenue generated through such New Business Services shall exclude
price escalators and cost-of-living adjustments. Any Additional Compensation
or
Incentive Compensation paid to Consultant shall be in addition to the Per Diem
Amount. All compensation earned by Consultant shall be subject to all applicable
state and federal tax obligations. For purposes of this Agreement, “New Business
Services” shall mean new site contracts between the Company and new detention
facilities, as well as new services added to the Company’s current site
contracts, including but not limited to, pharmaceutical services, mental health
services, dental services, employee physicals and third party
administration.
(c) Any
and
all amounts of Additional Compensation or Incentive Compensation to which
Consultant is entitled shall be payable within 45 days after the close of each
applicable calendar quarter.
3.3 Stock
Options.
From
time to time the Company may grant to Consultant options under the Company’s
2007 Stock Option Plan (or its successor stock plan) to purchase shares of
the
Company’s common stock at a stated exercise price per share.
3.4 Benefits.
Consultant shall not be eligible for or entitled to any and all benefits
provided by the Company to its employees.
3.5 Reimbursement
of Expenses.
Consultant shall be entitled to be reimbursed for all reasonable expenses,
including but not limited to expenses for travel for business, as appropriate,
business meals and entertainment, incurred by Consultant in performing its
Services. The Company shall reimburse Consultant for travel expenses for
business purposes with respect to a vehicle of Consultant’s choice, including
but not limited to, tolls, gasoline and parking. In addition to the
reimbursement of such travel expenses, Consultant shall be entitled to a monthly
car allowance in the amount of $800 per month to be paid by the Company. Such
monthly car allowance shall be subject to all applicable state and federal
tax
obligations. Consultant shall submit expense reports and receipts documenting
the expenses incurred in accordance with Company policy as provided. The
Company’s obligation to reimburse authorized expenses incurred or accrued prior
to termination of this Agreement shall survive any such
termination.
2
4. Change
of Control.
In the
event of a Change of Control (as defined below) of the Company, all options
and
other equity incentives then granted to Consultant, if any, which are unvested
at the date of the Change of Control shall immediately vest and be
exercisable.
As
used
herein, a “Change of Control” of the Company shall mean any of the following:
(i) the acquisition by any person(s) (individual, entity or affiliated or
unaffiliated group) in one or a series of transactions (including, without
limitation, issuance of shares by the Company or through merger of the Company
with another entity) of direct or indirect record or beneficial ownership of
50%
or more of the voting power with respect to matters put to the vote of the
shareholders of the Company and, for this purpose, the terms “person” and
“beneficial ownership” shall have the meanings provided in Section 13(d) or
14(d) of the Securities Exchange Act of 1934 or related rules promulgated by
the
Securities and Exchange Commission; (ii) the commencement of or public
announcement of an intention to make a tender or exchange offer for more than
50% of the then outstanding Shares of the common stock of the Company; or (iii)
a sale of all or substantially all of the assets of the Company. Notwithstanding
the foregoing, the following acquisitions shall not constitute a “Change of
Control”: (1) the capital raise and the closing of the merger between the
Company and ConMed, Inc. with the Company as the surviving entity; (2) the
consummation of the expected Plan of Recapitalization disclosed in the
Confidential Private Placement Memorandum, dated September 13, 2006; (3) the
closing of any transaction that in good faith may be reasonably characterized
as
an acquisition of another entity by the Company rather than the other way
around; or (4) any acquisition of the Company or its shares by any employee
benefit plan (or related trust) sponsored or maintained by the Company or any
corporation controlled by the Company.
5. Termination.
5.1 Termination.
Either
party may terminate the Agreement at any time for any reason with 90 days’ prior
written notice to the other party.
5.2 Effects
of Termination.
(a) Upon
termination of this Agreement, the Company will promptly pay Consultant all
Per
Diem Amounts owed to Consultant, as previously defined in writing by the
Company, and unpaid through the date of termination (including, without
limitation, expense reimbursements).
(b) Upon
termination of this Agreement, Consultant or any of its members agree that
for
the three (3) year period following the date of such termination or during
the
period that Consultant or any of its members are an owner of any issued and
outstanding stock of the Company:
(i) Consultant
or any of its members will not directly or indirectly, whether as a director,
consultant or advisor, or in any other capacity whatsoever other than a passive
investor or an owner of more than five percent (5%) of the issued and
outstanding shares of stock of any such entity, provide services to any person,
firm, corporation or other business enterprise located in any state in which
the
Company is doing business, which is involved in the business of providing
healthcare services or management services to jails, prisons, or correctional
facilities in direct competition with the Company, unless Consultant or such
member obtains the Company’s prior written consent.
3
(ii) Consultant
or any of its members will not knowingly, directly and actively solicit any
individual to leave the Company’s then full-time employ, for any reason, to join
or be employed by any employer that then employs Consultant or any of its
members as an employee, director, consultant or advisor.
(iii) Consultant
or any of its members will not knowingly, directly and actively induce any
provider, agent, customer, supplier, distributor, or licensee of the Company
to
cease doing business with the Company or to breach its agreement with the
Company.
(c) Consultant
or any of its members acknowledge that monetary damages may not be sufficient
to
compensate the Company for any economic loss, which may be incurred by reason
of
breach of the restrictive covenants set forth in Section 5.2(b). Accordingly,
in
the event of any such breach, the Company shall, in addition to any remedies
available to the Company at law, be entitled to seek equitable relief in the
form of an injunction, precluding Consultant or such member from continuing
to
engage in such breach.
(d) If
any
restriction set forth in Section 5.2(b) is held to be unreasonable, then
Consultant or any of its members and the Company agree, and hereby submit,
to
the reduction and limitation of such prohibition to such area or period as
shall
be deemed reasonable.
(e) In
the
event of termination of this Agreement, Consultant and any of its members agree
not to make to any person, including but not limited to customers of the
Company, any statement that disparages the Company or which reflects negatively
upon the Company, including but not limited to statements regarding the
Company’s financial condition, its officers, directors, shareholders, employees
and affiliates. The Company agrees not to make to any person, including but
not
limited to customers of the Company, any statement that disparages Consultant
or
any of its members or which reflects negatively upon Consultant or any of its
members, including but not limited to statements regarding Consultant’s
financial condition.
6. Confidentiality.
This
Agreement with the Company shall be contingent upon Consultant’s execution of,
and the Company’s receipt of the Non-Competition, Non-Solicitation and
Confidentiality Agreement, substantially in the form attached hereto as
Exhibit
A.
7. Indemnification.
Consultant and its members assume liability for, and shall indemnify, defend,
protect, save and hold the Company harmless from and against any and all claims,
actions, suits, costs, liabilities, judgments, obligations, losses, payments,
interests, penalties, taxes (including employee withholding taxes), damages
and
expenses (including reasonable legal fees and expenses) or other liabilities
of
whatsoever kind or nature, incurred by the Company resulting from, based upon,
relating to or arising out of the Consultant’s relationship with the Company
pursuant to this Agreement, the Consultant’s performance of its Services under
this Agreement or any breach or alleged breach of any of Consultant’s
representations, covenants or obligations made pursuant to this
Agreement.
4
8. General
Provisions.
8.1 Assignment.
Neither
party may assign or delegate any of its rights or obligations under this
Agreement without the prior written consent of the other party.
8.2 Entire
Agreement.
This
Agreement contains the entire agreement between the parties with respect to
the
subject matter hereof and supersedes any and all prior written and verbal
agreements between the parties.
8.3 Modifications.
This
Agreement may be changed or modified only by an agreement in writing signed
by
both parties hereto.
8.4 Successors
and Assigns.
The
provisions of this Agreement shall inure to the benefit of, and be binding
upon,
the Company and its successors and permitted assigns and Consultant and its
successors and permitted assigns by operation of law, whether or not any such
person shall have become a party to this Agreement and have agreed in writing
to
join and be bound by the terms and conditions hereof.
8.5 Governing
Law.
This
Agreement shall be governed by, construed and enforced in accordance with,
the
laws of the State of Delaware, and venue and jurisdiction for any disputes
hereunder shall be heard in any court of competent jurisdiction in Delaware
for
all purposes.
8.6 Severability.
If any
provision of this Agreement is held by a court of competent jurisdiction to
be
invalid, void or unenforceable, the remaining provisions shall nevertheless
continue in full force and effect.
8.7 Further
Assurances.
The
parties will execute such further instruments and take such further actions
as
may be reasonably necessary to carry out the intent of this
Agreement.
8.8 Notices.
Any
notices or other communications required or permitted hereunder shall be in
writing and shall be deemed received by the recipient when delivered personally
or, if mailed, five (5) days after the date of deposit in the United States
mail, certified or registered, postage prepaid and addressed, in the case of
the
Company, to its corporate headquarters, attention Chairman of the Board, and
in
the case of Consultant, to the address shown for Consultant on the signature
page hereof, or to such other address as either party may later specify by
at
least ten (10) days advance written notice delivered to the other party in
accordance herewith.
8.9 No
Waiver.
The
failure of either party to enforce any provision of this Agreement shall not
be
construed as a waiver of that provision, nor prevent that party thereafter
from
enforcing that provision of any other provision of this Agreement.
8.10 Legal
Fees and Expenses.
In the
event of any disputes under this Agreement, the prevailing party or parties
shall be reimbursed by the party or parties who do not prevail for their
reasonable attorneys, accountants and expert fees and related expenses and
for
the costs of such proceeding.
5
8.11 Counterparts.
This
Agreement may be executed by exchange of facsimile signature pages and/or in
counterparts, each of which shall be deemed to be an original, but all of which
together shall constitute one and the same instrument.
IN
WITNESS WHEREOF, the Company and Consultant have executed this Agreement,
effective as of the day and year first above written.
PACE
Health Management Systems, Inc.
By:
/s/
Xxxxxxx
Xxxxxx
Name:
Xxxxxxx Xxxxxx, PH.D.
Title:
President
CONSULTANT:
YANKEE
PARTNERS, LLC
By: /s/
Xxxxxx X.
Xxxxxxx
Name:
Xxxxxx X. Xxxxxxx
Title:
Member
Address:
/s/ Xxxxxx X.
Xxxxxxx
Xxxxxx
X.
Xxxxxxx,
for
purposes of §§5.2(b), (c), (d) and (e), and 6 only
6
SCHEDULE
I
MARYLAND
ACCOUNTS
Site
|
1st
Qtr 2007
Forecast
|
2nd
Qtr 2007
Forecast
|
3rd
Qtr 2007
Forecast
|
4th
Qtr 2007
Forecast
|
Annual
2007
Forecast
|
Current
Contracts
|
|||||
Allegany,
MD
|
$188,024
|
$188,024
|
$195,545
|
$195,545
|
$767,138
|
Baltimore,
MD
|
1,514,308
|
1,514,308
|
1,574,880
|
1,574,880
|
6,178,376
|
Calvert,
MD
|
64,753
|
64,753
|
67,343
|
67,343
|
264,192
|
Xxxxxxx,
MD
|
99,922
|
99,922
|
103,919
|
103,919
|
407,682
|
Xxxxx,
MD
|
311,530
|
311,530
|
323,991
|
323,991
|
1,271,042
|
Xxxxxxx
Co,, MD
|
416,098
|
416,098
|
432,742
|
432,742
|
1,697,680
|
CCSO-Xxxxxxx,
MD
|
12,000
|
12,000
|
12,480
|
12,480
|
48,960
|
Dorchester,
MD
|
68,535
|
68,535
|
71,276
|
71,276
|
279,622
|
Frederick,
MD
|
325,000
|
325,000
|
338,000
|
338,000
|
1,326,000
|
Harford,
MD
|
507,735
|
507,735
|
528,044
|
528,044
|
2,071,558
|
Xxxxxx,
MD
|
323,782
|
323,782
|
336,733
|
336,733
|
1,321,030
|
Kent,
MD
|
48,154
|
48,154
|
50,080
|
50,080
|
196,468
|
Xxxxx
Xxxx, MD
|
47,096
|
47,096
|
48,980
|
48,980
|
192,152
|
St
Mary's, MD
|
102,283
|
102,283
|
106,374
|
106,374
|
417,314
|
SMD
St Mary's, MD
|
5,081
|
5,081
|
5,284
|
5,284
|
20,730
|
SMTF
St Mary's, MD
|
13,700
|
13,700
|
14,248
|
14,248
|
55,896
|
Somerset,
MD
|
73,903
|
73,903
|
76,859
|
76,859
|
301,524
|
Talbot,
MD
|
71,420
|
71,420
|
74,277
|
74,277
|
291,394
|
Totals
|
4,193,324
|
4,193,324
|
4,361,055
|
4,361,055
|
17,108,758
|
7
EXHIBIT
A
NON-COMPETITION,
NON-SOLICITATION AND
CONFIDENTIALITY
AGREEMENT
This
NON-COMPETITION, NON-SOLICITATION AND CONFIDENTIALITY AGREEMENT (this
“Agreement”)
is
entered into effective for all purposes as of this ___ day of _______, 2007
by
Yankee Partners, LLC and its sole member, Xxxxxx X. Xxxxxxx, (collectively,
the
“Consultant”)
in
favor of ConMed, Inc., a Maryland corporation, and/or any of its affiliates,
parents, subsidiaries or other related entities (collectively, the “Company”).
In
consideration and as a condition of Consultant’s agreement with the Company,
Consultant hereby agrees as follows:
1. Confidentiality.
At all
times, Consultant shall keep confidential, except as the Company may otherwise
consent to in writing, and not disclose, or make any use of except for the
benefit of the Company and in no way competitive with the Company, at any time
either during or subsequent to performance by Consultant of services for the
Company, any trade secrets, confidential information, knowledge, data or other
information of the Company relating to products, processes, know-how, technical
data, designs, formulas, test data, customer lists, business plans, marketing
plans and strategies, and pricing strategies or other subject matter pertaining
to any business of the Company or any of its clients, customers, consultants,
licensees or affiliates (collectively, the “Confidential
Information”),
which
Consultant may produce, obtain or otherwise learn of during the course of
Consultant’s performance of services and after the cessation
of Consultant’s agreement with
the
Company. Consultant shall not deliver, reproduce, or in any way allow any such
Confidential Information to be delivered to or used by any third parties without
the specific direction or consent of an authorized representative of the
Company.
As
used
in this Agreement, the term “cessation
of Consultant’s services to the Company”
shall
mean any separation from Consultant providing services to the Company, either
voluntarily or involuntarily, either with cause or without cause, or whether
the
separation is at the behest of the Company or Consultant.
2. Return
of Confidential Material.
Upon
the cessation
of Consultant’s services
to the
Company, Consultant shall promptly surrender and deliver to the Company all
records, materials, equipment, drawings, documents, lab notes and books and
data
of any nature pertaining to any Confidential Information of the Company or
to
the services provided by Consultant, and Consultant will not take or retain
(in
any form or format) any description containing or pertaining to any Confidential
Information which Consultant may produce or obtain during the course of the
Consultant’s association with the Company.
3. Trade
Secrets of Others.
Consultant represents that its performance of all the terms of this Agreement
and as a consultant of the Company does not and will not breach any agreement
to
keep in confidence proprietary information, knowledge or data acquired by
Consultant in confidence or in trust, and Consultant will not disclose to the
Company, or induce the Company to use, any confidential or proprietary
information or material belonging to any other person or entity. Consultant
will
not enter into any agreement, either written or oral, in conflict
herewith.
8
4. Non-Competition;
Non-Solicitation. For
purposes of this Agreement, the term “Competitive
Activity”
shall
mean engaging in the business of providing medical healthcare services to
detention facilities. Consultant will not knowingly do, or prepare to do, any
of
the following, either
individually or through any entity controlled by Consultant, and either on
Consultant’s behalf or on behalf of any other person or entity competing or
endeavoring to compete with the Company, directly or indirectly, during
Consultant’s services to the Company and during the period of two (2) years
after the cessation of Consultant’s services to the Company, in the states
within which the Company conducts its business:
(a) Own,
manage, operate, control, consult for, be an officer or director of, work for,
or be employed in any capacity by any corporation, partnership, limited
liability company, educational or not-for-profit institution or any other
business, entity, agency or organization which is in any way involved in the
Competitive Activity; or
(b) Solicit
prior or current customers, collaborators, joint venturers or other business
affiliations of the Company for any purpose associated with a Competitive
Activity; or
(c) Solicit
for
employment or retention (or, following such solicitation, employ or retain)
as
an employee, independent contractor or agent, any
employees or consultants of the Company to engage in, either with the Consultant
or in any other capacity, any Competitive Activity.
In
the
event that Consultant improperly competes with the Company in any manner set
forth above, the period during which Consultant engages in such competition
shall not be counted in determining the duration of the two (2) year non-compete
restriction.
5. Injunctive
Relief.
Consultant acknowledges that any breach or attempted breach by Consultant of
this Agreement or any provision hereof shall cause the Company irreparable
harm
for which any adequate monetary remedy does not exist. Accordingly, in the
event
of any such breach or threatened breach, the Company shall be entitled to obtain
injunctive relief, without the necessity of posting a bond or other surety,
restraining such breach or threatened breach.
6. Modification.
This
Agreement may not be changed, modified, released, discharged, abandoned, or
otherwise amended, in whole or in part, except by an instrument in writing,
signed by Consultant and by the Company. Any subsequent change or changes in
the
relationship between the Company and Consultant or in Consultant’s compensation
by the Company shall not affect the validity or scope of this
Agreement.
7. Reasonable
Terms.
Consultant acknowledges and agrees that the restrictive covenants contained
in
this Agreement have been reviewed by Consultant with the benefit of counsel
and
that such covenants are reasonable in all of the circumstances for the
protection of the legitimate interests of the Company.
9
8. Entire
Agreement.
Consultant acknowledges receipt of this Agreement, and agrees that with respect
to the subject matter thereof it is Consultant’s entire agreement with the
Company, superseding any previous oral or written communications,
representations, understandings, or agreements with the Company or any officer
or representative thereof.
9. Severabilitv.
In the
event that any paragraph or provision of this Agreement shall be held to be
illegal or unenforceable, the entire Agreement shall not fail on account
thereof. It is further agreed that if any one or more of such paragraphs or
provisions shall be judged to be void as going beyond what is reasonable in
all
of the circumstances for the protection of the interests of the Company, but
would be valid if part of the wording thereof were deleted or the period thereof
reduced or the range of activities covered thereby reduced in scope, the said
reduction shall be deemed to apply with such modifications as may be necessary
to make them valid and effective and any such modification shall not thereby
affect the validity of any other paragraph or provisions contained in this
Agreement.
10. Successors
and Assigns.
This
Agreement shall be binding upon the heirs, executors, administrators or other
legal representatives of Consultant and is for the benefit of the Company,
its
successors and assigns.
11. Governing
Law.
This
Agreement shall be governed by the laws of the State of Delaware except for
any
conflicts of law rules thereof which might direct the application of the
substantive laws of another state.
10
IN
WITNESS WHEREOF, the undersigned have executed this Agreement as of the date
first forth above.
CONSULTANT: | ||
YANKEE PARTNERS, LLC | ||
|
|
|
By: | ||
Name:
Xxxxxx X. Xxxxxxx
Title:
Member
|
||
Xxxxxx
X. Xxxxxxx
|
CONMED, INC. | ||
|
|
|
By: | ||
Name:
Xxxxxxx Xxxxxx, PH.D.
Title:
Chief Executive Officer
|
||
11